Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for AVTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 306.80M
March 31, 2026 279.30M
December 31, 2025 365.40M
September 30, 2025 251.90M
June 30, 2025 449.40M
March 31, 2025 315.70M
December 31, 2024 261.90M
September 30, 2024 285.30M
June 30, 2024 272.60M
March 31, 2024 234.90M
December 31, 2023 262.90M
September 30, 2023 236.90M
June 30, 2023 236.40M
March 31, 2023 294.60M
December 31, 2022 372.90M
September 30, 2022 265.60M
June 30, 2022 237.50M
March 31, 2022 283.60M
Date Value
December 31, 2021 301.70M
September 30, 2021 1.426B
June 30, 2021 223.00M
March 31, 2021 172.50M
December 31, 2020 286.60M
September 30, 2020 370.50M
June 30, 2020 415.30M
March 31, 2020 346.30M
December 31, 2019 186.70M
September 30, 2019 173.90M
June 30, 2019 164.60M
March 31, 2019 143.90M
December 31, 2018 184.70M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017 185.40M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. 502.69M
Champions Oncology, Inc. 4.872M
Personalis, Inc. 212.66M
Adaptive Biotechnologies Corp. 344.26M
10X Genomics, Inc. 552.03M